What to watch after Friday’s close as FDA review scrutiny and Novo’s pill data hit
New York, January 18, 2026, 10:06 EST — Market closed
- On Friday, Eli Lilly shares ended the day at $1,038.40, marking a 0.5% rise.
- Attention is now on when fast FDA reviews will land and how solid they’ll be legally, alongside what early prescription numbers reveal about the coming obesity-drug competition.
- The U.S. markets will be closed Monday. Trading resumes Tuesday, with Lilly’s earnings call for Feb. 4 coming up next.
Eli Lilly shares ended Friday at $1,038.40, rising 0.5% after fluctuating between $1,019 and $1,049.83 during the session. With U.S. markets shut for the weekend, traders are left to digest regulatory and competitive developments ahead of Monday’s open.
Why it matters now: Lilly’s…
